These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 17937464

  • 1. Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.
    Laroche M, Borg S, Lassoued S, De Lafontan B, Roché H.
    J Rheumatol; 2007 Nov; 34(11):2259-63. PubMed ID: 17937464
    [Abstract] [Full Text] [Related]

  • 2. Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial.
    Sestak I, Sapunar F, Cuzick J.
    J Clin Oncol; 2009 Oct 20; 27(30):4961-5. PubMed ID: 19752338
    [Abstract] [Full Text] [Related]

  • 3. Clinical and laboratory features of Sjögren's syndrome in young women with previous postpartum thyroiditis.
    Gudbjörnsson B, Karlsson-Parra A, Karlsson E, Hällgren R, Kämpe O.
    J Rheumatol; 1994 Feb 20; 21(2):215-9. PubMed ID: 8182627
    [Abstract] [Full Text] [Related]

  • 4. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
    Lycette JL, Luoh SW, Beer TM, Deloughery TG.
    Breast Cancer Res Treat; 2006 Oct 20; 99(3):249-55. PubMed ID: 16752073
    [Abstract] [Full Text] [Related]

  • 5. Tolerance of adjuvant letrozole outside of clinical trials.
    Fontaine C, Meulemans A, Huizing M, Collen C, Kaufman L, De Mey J, Bourgain C, Verfaillie G, Lamote J, Sacre R, Schallier D, Neyns B, Vermorken J, De Grève J.
    Breast; 2008 Aug 20; 17(4):376-81. PubMed ID: 18455395
    [Abstract] [Full Text] [Related]

  • 6. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R.
    Eur J Surg Oncol; 2008 Jul 20; 34(7):746-55. PubMed ID: 18296017
    [Abstract] [Full Text] [Related]

  • 7. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
    Bundred NJ, Campbell ID, Davidson N, DeBoer RH, Eidtmann H, Monnier A, Neven P, von Minckwitz G, Miller JC, Schenk NL, Coleman RE.
    Cancer; 2008 Mar 01; 112(5):1001-10. PubMed ID: 18205185
    [Abstract] [Full Text] [Related]

  • 8. A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.
    Chino A, Okamoto H, Hirasaki Y, Ueda K, Ogawa K, Namiki T.
    J Altern Complement Med; 2011 Nov 01; 17(11):1075-7. PubMed ID: 22070441
    [Abstract] [Full Text] [Related]

  • 9. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
    Coleman RE, Bolten WW, Lansdown M, Dale S, Jackisch C, Merkel D, Maass N, Hadji P.
    Cancer Treat Rev; 2008 May 01; 34(3):275-82. PubMed ID: 18082328
    [Abstract] [Full Text] [Related]

  • 10. Sjögren's syndrome and aromatase inhibitors treatment: is there a link?
    Guidelli GM, Martellucci I, Galeazzi M, Francini G, Fioravanti A.
    Clin Exp Rheumatol; 2013 May 01; 31(4):653-4. PubMed ID: 23558055
    [No Abstract] [Full Text] [Related]

  • 11. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
    Morales L, Pans S, Verschueren K, Van Calster B, Paridaens R, Westhovens R, Timmerman D, De Smet L, Vergote I, Christiaens MR, Neven P.
    J Clin Oncol; 2008 Jul 01; 26(19):3147-52. PubMed ID: 18474874
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
    Ceribelli A, Cavazzana I, Cattaneo R, Franceschini F.
    Autoimmun Rev; 2008 Dec 01; 8(2):92-4. PubMed ID: 18692602
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.
    Mouridsen H, Keshaviah A, Coates AS, Rabaglio M, Castiglione-Gertsch M, Sun Z, Thürlimann B, Mauriac L, Forbes JF, Paridaens R, Gelber RD, Colleoni M, Smith I, Price KN, Goldhirsch A.
    J Clin Oncol; 2007 Dec 20; 25(36):5715-22. PubMed ID: 17998546
    [Abstract] [Full Text] [Related]

  • 14. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
    Dixon JM.
    Expert Rev Anticancer Ther; 2008 Mar 20; 8(3):453-63. PubMed ID: 18366292
    [Abstract] [Full Text] [Related]

  • 15. Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.
    Kubo M, Onishi H, Kuroki S, Okido M, Shimada K, Yokohata K, Umeda S, Ogawa T, Tanaka M, Katano M.
    Anticancer Res; 2012 Jun 20; 32(6):2331-6. PubMed ID: 22641670
    [Abstract] [Full Text] [Related]

  • 16. Toxicity of aromatase inhibitors.
    Pandya N, Morris GJ.
    Semin Oncol; 2006 Dec 20; 33(6):688-95. PubMed ID: 17145349
    [Abstract] [Full Text] [Related]

  • 17. Paucity of anti-hepatitis C virus antibodies in the serum of Indian patients with Sjogren's syndrome and inflammatory myositis.
    Wanchu A, Chawla Y, Dhiman RK, Sud A, Bambery P.
    Indian J Pathol Microbiol; 2003 Apr 20; 46(2):191-3. PubMed ID: 15022906
    [Abstract] [Full Text] [Related]

  • 18. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
    Wardley AM.
    Adv Ther; 2008 Dec 20; 25(12):1257-75. PubMed ID: 19096768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.